Related Experiment Video

Updated: Jul 24, 2025

Assessment of Global DNA Double-Strand End Resection using BrdU-DNA Labeling coupled with Cell Cycle Discrimination Imaging
06:44

Assessment of Global DNA Double-Strand End Resection using BrdU-DNA Labeling coupled with Cell Cycle Discrimination Imaging

Published on: April 28, 2021

4.0K

Recent Research Advances in Double-Strand Break and Mismatch Repair Defects in Prostate Cancer and Potential Clinical

Damian Jaworski1,2, Bartosz Brzoszczyk3, Łukasz Szylberg4,5

  • 1Department of Clinical Pathomorphology, Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University in Torun, 85-067 Bydgoszcz, Poland.

Cells
|July 6, 2023
PubMed

Insights

Prostate cancer progression is linked to DNA repair defects. Targeting mismatch repair (MMR) and double-strand break (DSB) pathways with novel therapies shows promise for improved patient outcomes.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Prostate cancer is a significant cause of male cancer mortality globally.
  • DNA repair mechanisms, specifically mismatch repair (MMR) and double-strand break (DSB) repair, are increasingly recognized for their roles in prostate cancer.
  • Defects in these pathways can drive tumor development and progression.

Purpose of the Study:

  • To comprehensively review the molecular mechanisms of MMR and DSB defects in prostate cancer.
  • To explore the clinical implications of these DNA repair deficiencies.
  • To discuss the therapeutic potential of targeting MMR and DSB defects.

Main Methods:

  • Literature review of molecular mechanisms.
  • Analysis of clinical implications and trial data.
  • Discussion of therapeutic strategies including immune checkpoint inhibitors and PARP inhibitors.

Main Results:

  • MMR and DSB defects play critical roles in prostate cancer pathogenesis.
  • Targeting these defects with specific inhibitors has shown efficacy in recent clinical trials.
  • FDA approvals indicate the clinical viability of these novel therapeutic approaches.

Conclusions:

  • Understanding the interplay between MMR and DSB defects is crucial for prostate cancer treatment.
  • Personalized medicine approaches targeting these defects offer significant therapeutic potential.
  • Novel therapies like immune checkpoint inhibitors and PARP inhibitors represent a hopeful advancement for patients.
Keywords:
PARP inhibitorsdouble-strand breakmismatch repairprostate cancer

More Related Videos

Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer13:19

Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer

Published on: November 2, 2013

16.6K
Visualizing and Quantifying Endonuclease-Based Site-Specific DNA Damage10:59

Visualizing and Quantifying Endonuclease-Based Site-Specific DNA Damage

Published on: August 21, 2021

3.7K

Related Concept Videos

Mismatch Repair01:20

Mismatch Repair

Organisms are capable of detecting and fixing nucleotide mismatches that occur during DNA replication. This sophisticated process requires identifying the new strand and replacing the erroneous bases with correct nucleotides. Mismatch repair is coordinated by many proteins in both prokaryotes and eukaryotes.
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
4.9K
Fixing Double-strand Breaks02:04

Fixing Double-strand Breaks

The double-stranded structure of DNA has two major advantages. First, it serves as a safe repository of genetic information where one strand serves as the back-up in case the other strand is damaged. Second, the double-helical structure can be wrapped around proteins called histones to form nucleosomes, which can then be tightly wound to form chromosomes. This way, DNA chains up to 2 inches long can be contained within microscopic structures in a cell. A double-stranded break not only damages...
12.7K
Long-patch Base Excision Repair01:02

Long-patch Base Excision Repair

Since the discovery of the two BER pathways, there has been a debate about how a cell chooses one pathway over the other and the factors determining this selection. Numerous in vitro experiments have pointed out multiple determinants for the sub-pathway selection. These are:
7.1K
Nucleotide Excision Repair01:38

Nucleotide Excision Repair

DNA Distortion and Damage
Cells are regularly exposed to mutagens—factors in the environment that can damage DNA and generate mutations. UV radiation is one of the most common mutagens and is estimated to introduce a significant number of changes in DNA. These include bends or kinks in the structure, which can block DNA replication or transcription. If these errors are not fixed, the damage can cause mutations, which in turn can result in cancer or disease depending on which sequences are...
3.6K